0.67 USD
↗ 0.04 (5.69%)AT CLOSE (11:59 AM EDT)
Mustang Bio, Inc.
MBIONASDAQ • USD
0.66
↘ 0.02 (2.25%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.66
↘ 0.02 (2.25%)
Market: CLOSED
Open?$0.63
High?$0.68
Low?$0.63
Prev. Close?$0.63
Volume?41.3K
Avg. Volume?43.9K
VWAP?$0.66
Rel. Volume?0.94x
Bid / Ask
Bid?$0.65 × 100
Ask?$0.66 × 100
Spread?$0.01
Midpoint?$0.66
Valuation & Ratios
Market Cap?5.1M
Shares Out?6.7M
Float?6.2M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?0.59
EPS?-$0.36
Dividend?0.00%
Ex-Dividend?N/A
MBIO is currently priced at $0.67. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of May 29, 2026.
News
Profile
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Themes
Employees
4
Market Cap
5.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2017-08-22
Address
95 SAWYER RD
WALTHAM, MA 02453
Phone: (781) 652-4500
WALTHAM, MA 02453
Phone: (781) 652-4500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-33.37Distress
Confidence?40%Low
Short InterestLow
Short % of Float?0.87%Low
Short Interest?53.6K
Days to Cover?1.3
Free Float6.2M
Avg Daily Volume40.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.12Strong
Quick Ratio?2.12Strong
Cash Ratio?2.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.59CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?3.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-31.7%WEAK▾
S&P6
ROA?-16.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-11181072
Fundamentals ratios updated end of day